KB

Krishna Bandi

Active Director Director DIN 10111024
DIN 10111024 First appointment Apr 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Krishna Bandi

Data last updated:

Krishna Bandi is a Director at Gnanamayee Pharmaceuticals Private Limited (since 2023). The company operates in Healthcare. Gnanamayee Pharmaceuticals Private Limited reported revenue of ₹24.6 Lakh (FY 2024).

DIN 10111024
Primary Designation Director
Industry Healthcare
First Appointment 11 Apr 2023
Oldest Company Age 3 yrs
Largest company Gnanamayee Pharmaceuticals Private Limited · ₹24.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Apr 20232023₹24.6 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Gnanamayee Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Krishna Bandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Bandi

Krishna Bandi currently holds 1 directorship: Gnanamayee Pharmaceuticals Private Limited (Director, since 11 Apr 2023, revenue ₹24.6 Lakh (FY 2024)).

Krishna Bandi was first appointed on 11 Apr 2023 as Director at Gnanamayee Pharmaceuticals Private Limited.

The current boards of Krishna Bandi's companies include Krishna Chaitanya Gorantla (Gnanamayee Pharmaceuticals Private Limited), Raghuveer Machiraju (Gnanamayee Pharmaceuticals Private Limited), Srinivas Reddy Badvel (Gnanamayee Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available